Literature DB >> 29299738

Recursive partitioning analysis is predictive of overall survival for patients undergoing spine stereotactic radiosurgery.

Ehsan H Balagamwala1, Jacob A Miller2, Chandana A Reddy1, Lilyana Angelov3,4, John H Suh1,4,5, Muhammad B Tariq2, Erin S Murphy1,4,5, Kailin Yang2, Toufik Djemil6, Anthony Magnelli1, Alireza M Mohammadi3,4, Sherry Soeder1, Samuel T Chao7,8,9.   

Abstract

Spine stereotactic radiosurgery (SRS) offers excellent radiographic and pain control for patients with spine metastases. We created a prognostic index using recursive partitioning analysis (RPA) to allow better patient selection for spine SRS. Patients who underwent single-fraction spine SRS for spine metastases were included. Primary histologies were divided into favorable (breast/prostate), radioresistant (renal cell/sarcoma/melanoma) and other. Cox proportional hazards regression was done to identify factors associated with overall survival (OS). RPA was performed to identify factors to classify patients into distinct risk groups with respect to OS. A total of 444 patients were eligible. Median dose was 16 Gy (range 8-18) in 1 fraction and median follow-up was 11.7 months. At time of analysis, 103 (23.1%) patients were alive. Median OS was 12.9 months. RPA identified three distinct classes. Class 1 was defined as KPS > 70 with controlled systemic disease (n = 142); class 3 was defined as KPS ≤ 70 and age < 54 years or KPS ≤ 70 age ≥ 54 years and presence of visceral metastases (n = 95); all remaining patients comprise class 2 (n = 207). Median overall survival was 26.7 months for class 1, 13.4 months for class 2, and 4.5 months for class 3 (p < 0.01). Our analysis demonstrates that there is considerably variability in survival among patients undergoing spine SRS. We created an objective risk stratification via RPA for spine SRS. Given the safety and efficacy of spine SRS and good survival in class 1 and 2 patients, this RPA can help clinicians identify patients who may benefit from upfront spine SRS.

Entities:  

Keywords:  Overall survival; Recursive partitioning analysis (RPA); Spine metastasis; Spine stereotactic radiosurgery

Mesh:

Year:  2018        PMID: 29299738     DOI: 10.1007/s11060-017-2716-1

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  17 in total

1.  Radiosurgery for spinal metastases: clinical experience in 500 cases from a single institution.

Authors:  Peter C Gerszten; Steven A Burton; Cihat Ozhasoglu; William C Welch
Journal:  Spine (Phila Pa 1976)       Date:  2007-01-15       Impact factor: 3.468

2.  A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database.

Authors:  Paul W Sperduto; Brian Berkey; Laurie E Gaspar; Minesh Mehta; Walter Curran
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-10-10       Impact factor: 7.038

3.  Clinical and Quality of Life Implications of Vertebral Compression Fracture Following Spine Radiosurgery.

Authors:  E H Balagamwala; J A Miller; L Angelov; J H Suh; A M Mohammadi; T Djemil; A Magnelli; S Soeder; S T Chao
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-10-01       Impact factor: 7.038

4.  Cost-effectiveness analysis of single fraction of stereotactic body radiation therapy compared with single fraction of external beam radiation therapy for palliation of vertebral bone metastases.

Authors:  Hayeon Kim; Malolan S Rajagopalan; Sushil Beriwal; M Saiful Huq; Kenneth J Smith
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-01-30       Impact factor: 7.038

5.  Single-fraction stereotactic body radiotherapy for spinal metastases from renal cell carcinoma.

Authors:  Ehsan H Balagamwala; Lilyana Angelov; Shlomo A Koyfman; John H Suh; Chandana A Reddy; Toufik Djemil; Grant K Hunter; Ping Xia; Samuel T Chao
Journal:  J Neurosurg Spine       Date:  2012-09-28

6.  Efficacy and cost-effectiveness analysis of external beam and stereotactic body radiation therapy in the treatment of spine metastases: a matched-pair analysis.

Authors:  Marsha L Haley; Peter C Gerszten; Dwight E Heron; Yue-Fang Chang; Dave S Atteberry; Steven A Burton
Journal:  J Neurosurg Spine       Date:  2011-02-11

7.  Predictive Value of Six Prognostic Scoring Systems for Spinal Bone Metastases: An Analysis Based on 1379 Patients.

Authors:  Laurens Bollen; Christine Wibmer; Yvette M Van der Linden; Willem Pondaag; Marta Fiocco; Wilco C Peul; Corrie A M Marijnen; Rob G H H Nelissen; Andreas Leithner; Sander P D Dijkstra
Journal:  Spine (Phila Pa 1976)       Date:  2016-02       Impact factor: 3.468

8.  The use of spine stereotactic radiosurgery for oligometastatic disease.

Authors:  Jennifer C Ho; Chad Tang; Brian J Deegan; Pamela K Allen; Eric Jonasch; Behrang Amini; Xin A Wang; Jing Li; Claudio E Tatsui; Laurence D Rhines; Paul D Brown; Amol J Ghia
Journal:  J Neurosurg Spine       Date:  2016-04-01

9.  Cost-utility analysis of the cyberknife system for metastatic spinal tumors.

Authors:  Frank J Papatheofanis; Erin Williams; Steven D Chang
Journal:  Neurosurgery       Date:  2009-02       Impact factor: 4.654

10.  Stereotactic Radiosurgery for the Treatment of Primary and Metastatic Spinal Sarcomas.

Authors:  Jacob A Miller; Ehsan H Balagamwala; Lilyana Angelov; John H Suh; Toufik Djemil; Anthony Magnelli; Peng Qi; Tingliang Zhuang; Andrew Godley; Samuel T Chao
Journal:  Technol Cancer Res Treat       Date:  2016-04-12
View more
  2 in total

1.  Using recursive partitioning approach to select tumor-associated antigens in immunodiagnosis of gastric adenocarcinoma.

Authors:  Jiejie Qin; Shuaibing Wang; Jianxiang Shi; Yan Ma; Keyan Wang; Hua Ye; Xiaojun Zhang; Peng Wang; Xiao Wang; Chunhua Song; Liping Dai; Kaijuan Wang; Binghua Jiang; Jianying Zhang
Journal:  Cancer Sci       Date:  2019-05-07       Impact factor: 6.716

Review 2.  Decision Making in Patients With Metastatic Spine. The Role of Minimally Invasive Treatment Modalities.

Authors:  Alfredo Conti; Güliz Acker; Anne Kluge; Franziska Loebel; Anita Kreimeier; Volker Budach; Peter Vajkoczy; Ilaria Ghetti; Antonino F Germano'; Carolin Senger
Journal:  Front Oncol       Date:  2019-09-19       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.